Evidence map›Paper›PMID 35996375›Full record

ArticleACS photonics2022

Tapered Optical Fibers Coated with Rare-Earth Complexes for Quantum Applications.

Ori Ezrah Mor, Tal Ohana, Adrien Borne, Yael Diskin-Posner, Maor Asher, Omer Yaffe, Abraham Shanzer, Barak Dayan

Open access · hybridAbstract read
In one paragraph

Article in ACS photonics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Rare Earths-The Answer to Everything.Molecules (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ori Ezrah MorDepartment of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID https://orcid.org/0000-0003-1089-643X
Tal OhanaDepartment of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Adrien BorneDepartment of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Yael Diskin-PosnerDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID https://orcid.org/0000-0002-9008-8477
Maor AsherDepartment of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID https://orcid.org/0000-0002-7529-2242
Omer YaffeDepartment of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID https://orcid.org/0000-0003-4114-7968
Abraham ShanzerDepartment of Molecular Chemistry and Material Science, Weizmann Institute of Science, Rehovot 7610001, Israel.
Barak DayanDepartment of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Weizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crystals and fibers doped with rare-earth (RE) ions provide the basis for most of today's solid-state optical systems, from lasers and telecom devices to emerging potential quantum applications such as quantum memories and optical to microwave conversion. The two platforms, doped crystals and doped fibers, seem mutually exclusive, each having its own strengths and limitations, the former providing high homogeneity and coherence and the latter offering the advantages of robust optical waveguides. Here we present a hybrid platform that does not rely on doping but rather on coating the waveguide-a tapered silica optical fiber-with a monolayer of complexes, each containing a single RE ion. The complexes offer an identical, tailored environment to each ion, thus minimizing inhomogeneity and allowing tuning of their properties to the desired application. Specifically, we use highly luminescent Yb

Identifiers

PMID35996375
PMCPMC9390790
OpenAlexW4288438272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.